Auriga Research operates a CDSCO (Central Drugs Standard Control Organisation) approved testing laboratory in India for pharmaceutical, medical device, and cosmetic product testing. Our test reports are accepted by CDSCO for new drug applications, medical device registrations, import licences, and regulatory compliance documentation.
The laboratory holds concurrent NABL accreditation under ISO/IEC 17025:2017 and USFDA registration, providing test data that meets both Indian and international regulatory requirements. Our analytical capabilities span chemical testing, microbiological analysis, biocompatibility studies, stability testing, and extractable/leachable analysis.
With over 700 scientists and technical staff across five laboratory facilities, Auriga Research provides the testing infrastructure, regulatory knowledge, and turnaround speed that pharmaceutical and medical device companies need for timely market access in India.
Multi-accredited facility providing test data accepted by Indian and international regulatory authorities.
Approved for pharmaceutical and medical device testing
Accredited under ISO/IEC 17025:2017
Registered facility for FDA-accepted testing
Scientists and technical staff across 5 labs
Comprehensive testing capabilities for regulated products requiring CDSCO-accepted test data.
Assay, dissolution, impurity profiling, content uniformity, stability studies (ICH), and microbiological testing per IP, USP, BP, and EP pharmacopoeias.
Learn moreBiocompatibility testing per ISO 10993, extractables and leachables, sterility, particulate matter, chemical characterisation, and performance testing.
Learn moreHeavy metals, preservative efficacy, microbiological limits, stability, pH, viscosity, and safety testing for cosmetic product notifications.
Learn moreICH-aligned long-term (25°C/60% RH), accelerated (40°C/75% RH), and intermediate stability studies with zone IV conditions for tropical markets.
Learn moreSterility testing, microbial limits, endotoxin (LAL), preservative efficacy, bioburden, and environmental monitoring per pharmacopoeial methods.
Learn moreCDSCO-approved clinical research including Phase I-III trials, bioanalytical testing, pharmacovigilance, and medical writing for regulatory submissions.
Learn moreCDSCO approved laboratory with NABL accreditation and USFDA registration. Pharmaceutical, medical device, and cosmetic product testing for regulatory submissions.
Download a practical testing guide tailored to your industry — checklists, parameters, and regulatory tips in one place.
Get Free Guide Request a Quote InsteadNo thanks, I'll keep browsing